Merck KGaA Fertility Business And Mavenclad Held Back By COVID-19 But Recovery Signs

Candidate Anti-COVID Toll-like Receptor Inhibitor Starts Phase II

 
• By John Davis
  
InVitro_Fertilisation
Lockdown Suppressed Sales Of Fertility Products • Source: Shutterstock

More from Earnings

More from Business